Pulse Biosciences, Inc. Available-for-sale Securities, Gross Gains (Losses), Derivatives (Deprecated 2018-01-31)
Pulse Biosciences, Inc. (PLSE) reported Available-for-sale Securities, Gross Gains (Losses), Derivatives (Deprecated 2018-01-31) of $48.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossGainsLossesNetDerivatives · last filed 2018-11-01
- Pulse Biosciences, Inc. available-for-sale securities, gross gains (losses), derivatives (deprecated 2018-01-31) for the quarter ending 2018-09-30 was -$3.00K, a 175.00% decline year-over-year.
- Pulse Biosciences, Inc. available-for-sale securities, gross gains (losses), derivatives (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $3.00K.
- Pulse Biosciences, Inc. available-for-sale securities, gross gains (losses), derivatives (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $48.00K.
- Pulse Biosciences, Inc. available-for-sale securities, gross gains (losses), derivatives (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $4.00K.
| Period end | Available-for-sale Securities, Gross Gains (Losses), Derivatives (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Gross Gains (Losses), Derivatives (Deprecated 2018-01-31) 6 month | Available-for-sale Securities, Gross Gains (Losses), Derivatives (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2018-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $48.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $51.00K 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $48.00K 10-Q · filed 2018-05-08 | ||
| 2017-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $5.00K 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $1.00K 10-Q · filed 2018-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |